Citigroup Inc Bio N Tech Se Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Citigroup Inc holds 157,941 shares of BNTX stock, worth $18.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

157,941

Previous 56,967 177.25%

Holding current value

$18.8 Million

Previous $5.26 Million 141.52%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$80.36 - $102.87 $8.11 Million - $10.4 Million	100,974 Added 177.25%	157,941 $12.7 Million
Q1 2024 May 10, 2024	BUY	$88.96 - $112.35 $132,016 - $166,727	1,484 Added 2.67%	56,967 $5.26 Million
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $858,644 - $1.06 Million	9,445 Added 20.52%	55,483 $5.86 Million
Q3 2023 Nov 09, 2023	SELL	$98.5 - $125.08 $2.08 Million - $2.64 Million	-21,141 Reduced 31.47%	46,038 $5 Million
Q2 2023 Aug 10, 2023	SELL	$102.58 - $129.66 $600,503 - $759,029	-5,854 Reduced 8.02%	67,179 $7.25 Million
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $2.19 Million - $2.75 Million	17,873 Added 32.4%	73,033 $9.1 Million
Q4 2022 Feb 09, 2023	SELL	$118.43 - $186.05 $4.21 Million - $6.62 Million	-35,568 Reduced 39.2%	55,160 $8.29 Million
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $3.1 Million - $4.45 Million	-24,286 Reduced 21.12%	90,728 $12.2 Million
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $746,278 - $1.13 Million	-6,055 Reduced 5.0%	115,014 $17.1 Million
Q1 2022 May 12, 2022	SELL	$126.25 - $231.85 $6.81 Million - $12.5 Million	-53,955 Reduced 30.83%	121,069 $20.6 Million
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $5.58 Million - $9.34 Million	25,767 Added 17.26%	175,024 $45.1 Million
Q3 2021 Nov 10, 2021	BUY	$205.93 - $447.23 $30.7 Million - $66.8 Million	149,257 New	149,257 $40.7 Million

Others Institutions Holding BNTX

# of Institutions

328

Shares Held

40.6M

Call Options Held

845K

Put Options Held

1.23M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account